title: Evaluation of serum lipids and high-density lipoprotein subfractions (HDL2, HDL3) in postmenopausal patients with breast cancer.
abstract: Breast cancer patients are known to be at increased risk for developing other chronic diseases including cardiovascular disease. Studies by different investigators have shown a correlation between increased dietary fat or hypercholesterolemia and the occurrence of breast cancer. Since previous studies on lipoprotein subfractions in this type of cancer have been inconsistent, we evaluated the lipids and lipoprotein subfraction levels in postmenopausal patients with breast cancer in an attempt to identify the risk for the development of cardiovascular disease. The study included 132 patients, 56 of which were suffering from breast cancer, 32 from pancreatic and 44 age-matched controls. Total cholesterol (TC), triglycerides and lipoprotein fractions as well as TC/High density lipoprotein (HDL) and HDL2/HDL3 ratios were estimated by standard laboratory techniques. An increase in triglycerides and a decrease in HDL-cholesterol, especially in the HDL2 subfraction, were observed in patients with breast cancer as compared to the controls (P < 0.05). The maximum changes in TC, and HDL concentrations were observed in patients with advanced disease. Analysis of indexes of atherosclerosis (TC/HDL, and HDL2/HDL3 ratios) demonstrated that breast cancer patients had significantly higher TC/HDL ratio (6.44+/-1.24) compared with controls (3.43+/-0.57, p = 0.001), and patients with pancreatic cancer (3.79+/-0.15, p = 0.027). The results have demonstrated an unfavourable lipid profile in untreated breast cancer patients with high atherosclerosis indexes. This observation is of great importance, considering the potential use of endocrine therapy that could result in further deterioration of lipid indexes. We propose the evaluation and monitoring of lipid profile prior and after the induction of hormonal therapy in breast cancer patients, as a routine in clinical setting.
authors.affiliation: Department of Biological Chemistry, University of Athens, School of Medicine, Athens, Greece.
authors.forename: V
authors.initials: V
authors.lastname: Michalaki
authors.forename: G
authors.initials: G
authors.lastname: Koutroulis
authors.forename: K
authors.initials: K
authors.lastname: Syrigos
authors.forename: C
authors.initials: C
authors.lastname: Piperi
authors.forename: A
authors.initials: A
authors.lastname: Kalofoutis
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001943:Breast Neoplasms / Q000097:blood* / Q000150:complications; D008076:Cholesterol, HDL / Q000097:blood*; D003324:Coronary Artery Disease / Q000097:blood / Q000150:complications; D005260:Female; D006801:Humans; D008075:Lipoproteins, HDL / Q000097:blood*; D053439:Lipoproteins, HDL2; D053440:Lipoproteins, HDL3; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000097:blood; D017698:Postmenopause / Q000097:blood*; D014280:Triglycerides / Q000097:blood*
chemical_list: D008076:Cholesterol, HDL; D008075:Lipoproteins, HDL; D053439:Lipoproteins, HDL2; D053440:Lipoproteins, HDL3; D014280:Triglycerides
references.citation: J Hematother Stem Cell Res. 2000 Apr;9(2):247-55
references.pmid: 10813538
references.citation: Eur J Cancer. 2001 Aug;37(12):1510-3
references.pmid: 11506958
references.citation: Clin Chem. 1988;34(8B):B78-83
references.pmid: 3042203
references.citation: Cancer Epidemiol Biomarkers Prev. 1998 Jun;7(6):483-8
references.pmid: 9641492
references.citation: Breast Cancer Res Treat. 1995 May;34(2):161-9
references.pmid: 7647333
references.citation: Am J Epidemiol. 1981 Jul;114(1):5-10
references.pmid: 7246530
references.citation: J Clin Oncol. 1996 Nov;14(11):3043-8
references.pmid: 8918503
references.citation: Am J Cardiol. 1992 Sep 15;70(7):733-7
references.pmid: 1519522
references.citation: Am J Med. 1977 May;62(5):707-14
references.pmid: 193398
references.citation: Lancet. 1985 Nov 23;2(8465):1150-4
references.pmid: 2865616
references.citation: Cancer Detect Prev. 1997;21(5):426-40
references.pmid: 9307846
references.citation: Cancer Epidemiol Biomarkers Prev. 1995 Mar;4(2):117-22
references.pmid: 7742718
references.citation: J Steroid Biochem Mol Biol. 2000 Dec 31;75(4-5):323-8
references.pmid: 11282289
references.citation: Int J Clin Lab Res. 2000;30(3):141-5
references.pmid: 11196072
references.citation: JAMA. 2002 Jul 17;288(3):321-33
references.pmid: 12117397
references.citation: Methods Biochem Anal. 1954;1:459-78
references.pmid: 13193538
references.citation: Clin Biochem. 2001 Feb;34(1):71-6
references.pmid: 11239519
references.citation: Adv Exp Med Biol. 1993;348:149-53
references.pmid: 8172018
references.citation: Breast Cancer Res Treat. 1995;36(3):287-97
references.pmid: 8573711
references.citation: J Lipid Res. 1984 Oct;25(10):1017-58
references.pmid: 6392459
references.citation: Clin Chim Acta. 1981 Aug 10;114(2-3):225-31
references.pmid: 7285347
references.citation: Cancer. 1987 Dec 15;60(12):3065-70
references.pmid: 3677028
references.citation: Endocr Relat Cancer. 1999 Jun;6(2):325-32
references.pmid: 10731126
references.citation: Surg Oncol. 1997 Nov;6(3):179-85
references.pmid: 9576633
references.citation: Annu Rev Nutr. 1992;12:391-416
references.pmid: 1503812
references.citation: Atherosclerosis. 1984 Sep;52(3):339-46
references.pmid: 6497936
references.citation: Nutr Cancer. 1997;27(3):284-92
references.pmid: 9101559
references.citation: Clin Chem. 1991 Dec;37(12):2093-101
references.pmid: 1764785
references.citation: Biochem Mol Biol Int. 1999 Apr;47(4):681-90
references.pmid: 10319421
references.citation: Clin Chem. 1982 Oct;28(10):2077-80
references.pmid: 6812986
references.citation: Clin Chem. 1974 Apr;20(4):470-5
references.pmid: 4818200